Rapid effect of Flutiform on pulmonary function compared with Relvar and Symbicort
Not Applicable
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000029379
- Lead Sponsor
- Tohno Chuo Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
<Visit 1> (1) Obvious COPD, ACO. (2) >=10 pack-years. (3) Patients who are not able to operate inhaler device. (4) Patients who used ICS/LABA or changed the dose of ICS during Run-in period. (5) Patients who inhaled Flutide Diskus before visit. (6) Chronic airway infection. (7) Patients who are complicated with severe liver, kidney and heart disease. (8) Patients who merger malignant tumor. (9) Patients who are pregnant or are likely to be pregnant. (10) Patients who are inadequate as the study subjects.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method